Jarred Younger, Noorulain Noor, Rebecca McCue, Sean Mackey
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.37734
Conclusion: The preliminary evidence continues to show that low-dose naltrexone has a specific and clinically beneficial impact on fibromyalgia pain. The medication is widely available, inexpensive, safe, and well-tolerated. Parallel-group randomized controlled trials are needed to fully determine the efficacy of the medication.
2 replies on “Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels”
I have been absent for a while, but now I remember why I used to love this website. Thanks , I will try and check back more often. How frequently you update your web site?
Thajks forr finallyy alking agout > Low-dose naltrexone forr tthe
treatment oof fibromyalgia: findints of a small, randomized,
double-blind, placebo-controlled, counterbalanced, rossover
trial assessing daily pazin lrvels – NALTREXONE.COM < Liked it!